Inflammation is a key contributor to cardiovascular disease (CVD), influencing both its onset and progression. High-sensitivity C-reactive protein (hsCRP) serves as a reliable biomarker for detecting ...

In this week’s View, Dr. Eagle highlights several important studies presented at the recent American Heart Association Scientific Sessions. The OCEAN Trial on antithrombotic and stroke prevention in ...

The U.S. Food and Drug Administration (FDA) has approved Cardamyst™ (etripamil) nasal spray to treat adults with paroxysmal supraventricular tachycardia (PSVT). This rapid-acting, self-adminstered ...

During ACC's 75th Anniversary, we're celebrating our legacy and preparing to shape the next 75 years. Help us invest in the future of cardiology with a gift to the ACC Foundation. Gifts support a ...

This episode is part of ACC’s ongoing initiative to advance heart failure (HF) care through team-based collaboration and patient-centered decision-making. Drs. Marty Tam, Lindsey Aurora, Leslie Davis, ...